First Horizon Advisors’s Collegium Pharmaceutical COLL Stock Holding History

First Horizon Advisors’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.45K	Buy	83 +24	+41%	+$685	﹤0.01%	1994
2025 Q1	$1.76K	Buy	59 +33	+127%	+$1.01K	﹤0.01%	2021
2024 Q4	$744	Hold	26	–	–	﹤0.01%	2138
2024 Q3	$1K	Hold	26	–	–	﹤0.01%	2136
2024 Q2	$837	Buy	+26	New	+$902	﹤0.01%	2144

Other funds holding COLL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

First Horizon Advisors's COLL Position: Q2 2025 in Review

First Horizon Advisors increased its Collegium Pharmaceutical (COLL) stake by 41% in Q2 2025, buying an estimated $685 and bringing the position to 83 shares worth $2.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1994.

First Horizon Advisors first reported a position in COLL in Q2 2024 and has held it in 5 quarters since. 223 funds tracked by Wall St. Rank hold COLL as of Q2 2025.

First Horizon Advisors held 83 shares of Collegium Pharmaceutical worth $2.45K as of Q2 2025.
First Horizon Advisors bought 24 Collegium Pharmaceutical shares in Q2 2025, an estimated $685.
Collegium Pharmaceutical made up ﹤0.01% of First Horizon Advisors's portfolio in Q2 2025, its #1994 holding.
First Horizon Advisors first reported a position in Collegium Pharmaceutical in Q2 2024 and has held it in 5 quarters since.
223 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2025.

Based on First Horizon Advisors's 13F filing for Q2 2025, filed 6 Aug 2025.